Literature DB >> 2936252

Cellular effects of hematoporphyrin derivative photodynamic therapy on normal and neoplastic rat bladder cells.

J R Shulok, J E Klaunig, S H Selman, P J Schafer, P J Goldblatt.   

Abstract

HPD is known to localize in neoplastic cells and when exposed to the appropriate wavelength of light causes cytotoxicity. The authors have established a rat urothelial cell model for use in comparing and contrasting the effects of HPD photodynamic therapy (PDT) in normal (RBL-01) and transitional cell carcinoma (AY27) bladder cell lines. Uptake, toxicity, and morphologic damage following exposure to HPD PDT were evaluated. Trypan blue exclusion was used for determination of the toxicity of several HPD concentrations (1, 10, 25, and 50 micrograms/ml) with increasing duration of incubation with HPD (0, 1, 2, 4, 12, 24, and 48 hours). Both cell lines displayed increased toxicity with higher concentrations of HPD; however, the AY27 cells were more susceptible to the toxic effects of HPD PDT than the RBL-01 cells at the higher HPD doses studied (25 and 50 micrograms/ml). Viability decreased with increased duration of HPD incubation in RBL-01 cells up until 4 hours, after which it showed a steady increase. Viability decreased in the AY27 cells with increased duration of HPD incubation. An increase in serum concentration in the medium resulted in an increase in viability for both cell lines. Both cell lines demonstrated fast initial uptake of HPD followed by slower uptake over the time studied. By 24 and 48 hours the AY27 cells contained twice the amount of methanol-extractable porphyrins as the RBL-01 cells. The initial morphologic change following HPD PDT was damage to mitochondria. Mitochondrial damage occurred immediately after PDT in the AY27 cells and 30 minutes after PDT in the RBL-01 cells. Both cell lines exhibited a similar progression of cell injury; however, morphologic damage was observed earlier after PDT and appeared more extensive in the AY27 cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936252      PMCID: PMC1888108     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Comparison of in vitro methods to determine drug-induced cell lethality.

Authors:  P R Roper; B Drewinko
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

2.  Identification of neoplastic versus normal cells in human cervical cell culture.

Authors:  B T Mossman; M J Gray; L Silberman; R L Lipson
Journal:  Obstet Gynecol       Date:  1974-05       Impact factor: 7.661

3.  Photodynamic therapy of malignant tumours.

Authors:  I Diamond; S G Granelli; A F McDonagh; S Nielsen; C B Wilson; R Jaenicke
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

4.  Superoxide dismutase. Organelle specificity.

Authors:  R A Weisiger; I Fridovich
Journal:  J Biol Chem       Date:  1973-05-25       Impact factor: 5.157

5.  The photodynamic modification of DNA by hematoporphyrin.

Authors:  B Gutter; W T Speck; H S Rosenkranz
Journal:  Biochim Biophys Acta       Date:  1977-03-18

Review 6.  Hematoporphyrin and HPD: photophysics, photochemistry and phototherapy.

Authors:  D Kessel
Journal:  Photochem Photobiol       Date:  1984-06       Impact factor: 3.421

7.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

Authors:  K R Weishaupt; C J Gomer; T J Dougherty
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

8.  Morphologic studies of bladder tumors treated with hematoporphyrin derivative photochemotherapy.

Authors:  J E Klaunig; S H Selman; J R Shulok; P J Schafer; S L Britton; P J Goldblatt
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

9.  Clonal growth and serial propagation of rat esophageal epithelial cells.

Authors:  M S Babcock; M R Marino; W T Gunning; G D Stoner
Journal:  In Vitro       Date:  1983-05

10.  Photosensitization of mitochondrial cytochrome c oxidase by hematoporphyrin derivative and related porphyrins in vitro and in vivo.

Authors:  S L Gibson; R Hilf
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

View more
  9 in total

1.  Studies on acute toxic effects to keratinocytes induced by hematoporphyrin derivatives and laser light.

Authors:  M Artuc; M Ramshad; H Kappus
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  Photo-immunotargeting with haematoporphyrin conjugates activated by a low-power He-Ne laser.

Authors:  T Berki; P Németh
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  The photodynamic effect of a pulsed dye laser on human bladder carcinoma cells in vitro.

Authors:  A J Pope; J R Masters; A J MacRobert
Journal:  Urol Res       Date:  1990

4.  Uptake and phototoxic effects of aluminum-chlorophthalocyanine (AlSPc) in human bladder carcinoma cells.

Authors:  K Miller; E Reich; T Grau; R Hautmann
Journal:  Urol Res       Date:  1994

5.  Photodynamic therapy of bladder cancer--uptake and phototoxicity of photosan in vitro.

Authors:  K Miller; E Reich; A Rück; R Hautmann
Journal:  Urol Res       Date:  1991

6.  A practical test for in vitro evaluation of photosensitization: assessment with hematoporphyrin derivative (HPD).

Authors:  A Croisy; D Carrez; D Zilberfarb
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

7.  Susceptibility of rodent cell lines to rat coronaviruses and differential enhancement by trypsin or DEAE-dextran.

Authors:  D J Gaertner; A L Smith; F X Paturzo; R O Jacoby
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo.

Authors:  J Leveckis; N J Brown; M W Reed
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

Review 9.  Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles.

Authors:  Yun-Jing Hou; Xin-Xin Yang; Rui-Qi Liu; Di Zhao; Chen-Xu Guo; An-Chao Zhu; Mei-Na Wen; Zhao Liu; Guo-Fan Qu; Hong-Xue Meng
Journal:  Int J Nanomedicine       Date:  2020-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.